Article citationsMore>>

Mahase, E. (2023) Alzheimer’s Disease: FDA Approves Lecanemab Amid Cost and Safety Concerns. The BMJ, 380, 73.
https://doi.org/10.1136/bmj.p73

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top